Global Plasma-derived Medicinal Products Market Research Report 2021

Plasma-derived medicinal products (PDMPs) are industrially manufactured from human plasma by pharmaceutical companies. Plasma is the liquid part of blood and it can be collected through specific procedures called plasmapheresis or obtained by the separation from the other components through physical means (centrifugation). PDMPs play a key, and sometimes non-replaceable, role in the treatment of many acute and chronic clinical conditions.

The global Plasma-derived Medicinal Products market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Plasma-derived Medicinal Products volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Plasma-derived Medicinal Products market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Plasma-derived Medicinal Products Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Immunoglobulins
Coagulation Factor Concentrates
Other

Segment by Application
Emergency Care
Epidemic Diseasae
Immune System Disorder
Antibody Deficiency
Coagulation Disorder
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Novartis(CSL Limited)
Biotest AG (Creat Group Corporation)
Grifols SA
Sigma-Aldrich
Thermo Fisher Scientific
Octapharma AG
Takeda
Kedrion
China Biologic Products
LFB Group

Frequently Asked Questions